CA Patent

CA2957297A1 — Hyperhidrosis treatment

Assigned to Dermira Inc · Expires 2016-03-03 · 10y expired

What this patent protects

Provided herein is an effective hyperhidrosis treatment, preferably a glycopyrronium compound, for use in methods of treating hyperhidrosis. Scoring hyperhidrosis, preferably in the form of an assessment, is disclosed.

USPTO Abstract

Provided herein is an effective hyperhidrosis treatment, preferably a glycopyrronium compound, for use in methods of treating hyperhidrosis. Scoring hyperhidrosis, preferably in the form of an assessment, is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA2957297A1
Jurisdiction
CA
Classification
—
Expires
2016-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Dermira Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.